Lentiviral vector production, titration, and transduction of primary neurons

Methods in Molecular Biology

Volumn 1018, Issue , 2013, Pages 119-131

  Ding, Baojin ^a   Kilpatrick, Daniel L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Immunofluorescence; Infection; Lentivirus; Primary neuron cultures; Titration; Transfection

Indexed keywords

CALCIUM PHOSPHATE; LENTIVIRUS VECTOR;

ARTICLE; CEREBELLAR GRANULE NEURON; CULTURE MEDIUM; DRUG PACKAGING; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NERVE CELL; NERVE CELL CULTURE; PRIORITY JOURNAL; TITRIMETRY; ULTRACENTRIFUGATION; VIRAL GENE DELIVERY SYSTEM; VIRUS PARTICLE;

LENTIVIRUS;

EID: 84883256189     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-444-9_12     Document Type: Article

References (26)

1. Lewis P, Hensel M, Emerman M (1992) Human immunode fi ciency virus infection of cells arrested in the cell cycle. EMBO J 11(8): 3053-3058
2. Weinberg JB, Matthews TJ, Cullen BR, Malim MH (1991) Productive human immunode fi ciency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J Exp Med 174(6):1477-1482
3. Matrai J, Chuah MK, VandenDriessche T (2010) Recent advances in lentiviral vector development and applications. Mol Ther 18(3):477-490
4. Delenda C (2004) Lentiviral vectors: optimization of packaging, transduction and gene expression. J Gene Med 6(Suppl 1): S125-S138
5. Zaiss AK, Son S, Chang LJ (2002) RNA 3 ¢ readthrough of oncoretrovirus and lentivirus: implications for vector safety and ef fi cacy. J Virol 76(14):7209-7219
6. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D (1998) Selfinactivating lentivirus vector for safe and ef fi cient in vivo gene delivery. J Virol 72(12):9873-9880
7. Frecha C, Szecsi J, Cosset FL, Verhoeyen E (2008) Strategies for targeting lentiviral vectors. Curr Gene Ther 8(6):449-460
8. Tiscornia G, Singer O, Verma IM (2006) Production and puri fi cation of lentiviral vectors. Nat Protoc 1(1):241-245
9. Zimmermann K, Scheibe O, Kocourek A, Muelich J, Jurkiewicz E, Pfeifer A (2011) Highly ef fi cient concentration of lenti-and retroviral vector preparations by membrane adsorbers and ultra fi ltration. BMC Biotechnol 11(1):55
10. Ichim CV, Wells RA (2011) Generation of high-titer viral preparations by concentration using successive rounds of ultracentrifugation. J Transl Med 9:137
11. Geraerts M, Willems S, Baekelandt V, Debyser Z, Gijsbers R (2006) Comparison of lentiviral vector titration methods. BMC Biotechnol 6:34
12. Logan AC, Nightingale SJ, Haas DL, Cho GJ, Pepper KA, Kohn DB (2004) Factors in fl uencing the titer and infectivity of lentiviral vectors. Hum Gene Ther 15(10):976-988
13. Scherr M, Battmer K, Blomer U, Ganser A, Grez M (2001) Quantitative determination of lentiviral vector particle numbers by real-time PCR. Biotechniques 31(3):520, 522, 524, passim
14. Ricks DM, Kutner R, Zhang XY, Welsh DA, Reiser J (2008) Optimized lentiviral transduction of mouse bone marrow-derived mesenchymal stem cells. Stem Cells Dev 17(3):441-450
15. Radcliffe PA, Sion CJ, Wilkes FJ, Custard EJ, Beard GL, Kingsman SM, Mitrophanous KA (2008) Analysis of factor VIII mediated suppression of lentiviral vector titres. Gene Ther 15(4):289-297
16. Wang W, Qu Q, Smith FI, Kilpatrick DL (2005) Self-inactivating lentiviruses: versatile vectors for quantitative transduction of cerebellar granule neurons and their progenitors. J Neurosci Methods 149(2):144-153
17. Lizee G, Aerts JL, Gonzales MI, Chinnasamy N, Morgan RA, Topalian SL (2003) Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression. Hum Gene Ther 14(6):497-507
18. Kutner RH, Zhang XY, Reiser J (2009) Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc 4(4):495-505
19. Wang W, Stock RE, Gronostajski RM, Wong YW, Schachner M, Kilpatrick DL (2004) A role for nuclear factor I in the intrinsic control of cerebellar granule neuron gene expression. J Biol Chem 279(51):53491-53497
20. Wang W, Mullikin-Kilpatrick D, Crandall JE, Gronostajski RM, Litwack ED, Kilpatrick DL (2007) Nuclear factor I coordinates multiple phases of cerebellar granule cell development via regulation of cell adhesion molecules. J Neurosci 27(23):6115-6127
21. Kumar P, Woon-Khiong C (2011) Optimization of lentiviral vectors generation for biomedical and clinical research purposes: contemporary trends in technology development and applications. Curr Gene Ther 11(2):144-153
22. Osten P, Dittgen T, Licznerski P (2006) Lentivirus-based genetic manipulations in neurons in vivo. In: Kittler JT, Moss SJ, editors. The Dynamic Synapse: Molecular Methods in Ionotropic Receptor Biology. Boca Raton (FL): CRC Press; 2006. Chapter 13.
23. Wang W, Shin Y, Shi M, Kilpatrick DL (2011) Temporal control of a dendritogenesis-linked gene via REST-dependent regulation of nuclear factor I occupancy. Mol Biol Cell 22(6): 868-879
24. Zufferey R, Donello JE, Trono D, Hope TJ (1999) Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73(4):2886-2892
25. VandenDriessche T, Thorrez L, Naldini L, Follenzi A, Moons L, Berneman Z, Collen D, Chuah MK (2002) Lentiviral vectors containing the human immunode fi ciency virus type-1 central polypurine tract can ef fi ciently transduce nondividing hepatocytes and antigen-presenting cells in vivo. Blood 100(3):813-822
26. Jordan M, Wurm F (2004) Transfection of adherent and suspended cells by calcium phosphate. Methods 33(2):136-143